390 related articles for article (PubMed ID: 16153857)
1. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.
Whiteside TL
Semin Cancer Biol; 2006 Feb; 16(1):3-15. PubMed ID: 16153857
[TBL] [Abstract][Full Text] [Related]
2. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
Stewart TJ; Smyth MJ
Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and lymphocyte persistence: implications in immunotherapy.
Mehrotra S; Mougiakakos D; Johansson CC; Voelkel-Johnson C; Kiessling R
Adv Cancer Res; 2009; 102():197-227. PubMed ID: 19595310
[TBL] [Abstract][Full Text] [Related]
4. Emerging strategies in regulatory T-cell immunotherapies.
Gajewski TF; Chesney J; Curriel TJ
Clin Adv Hematol Oncol; 2009 Jan; 7(1):1-10; quiz 11-2. PubMed ID: 19288606
[TBL] [Abstract][Full Text] [Related]
5. Immune cells as mediators of solid tumor metastasis.
DeNardo DG; Johansson M; Coussens LM
Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
[TBL] [Abstract][Full Text] [Related]
6. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
7. Reversal of tumor-mediated immunosuppression.
Vieweg J; Su Z; Dahm P; Kusmartsev S
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):727s-732s. PubMed ID: 17255301
[TBL] [Abstract][Full Text] [Related]
8. NK cell receptors as tools in cancer immunotherapy.
Sentman CL; Barber MA; Barber A; Zhang T
Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
[TBL] [Abstract][Full Text] [Related]
9. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
10. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
12. Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours?
Perret R; Ronchese F
Tissue Antigens; 2008 Sep; 72(3):187-94. PubMed ID: 18627571
[TBL] [Abstract][Full Text] [Related]
13. Immune suppression in the tumor microenvironment.
Gajewski TF; Meng Y; Harlin H
J Immunother; 2006; 29(3):233-40. PubMed ID: 16699366
[TBL] [Abstract][Full Text] [Related]
14. Targeting innate immune pathways in cancer immunotherapy: state of the art.
Mastellos DC
J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
[TBL] [Abstract][Full Text] [Related]
15. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
Mocellin S; Nitti D
Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
17. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
de Souza AP; Bonorino C
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic strategies employing RNA interference technology for the control of cancers.
Mao CP; Hung CF; Wu TC
J Biomed Sci; 2007 Jan; 14(1):15-29. PubMed ID: 17103251
[TBL] [Abstract][Full Text] [Related]
19. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Lizée G; Radvanyi LG; Overwijk WW; Hwu P
Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
[TBL] [Abstract][Full Text] [Related]
20. Suppression of anti-cancer immunity by regulatory T cells: back to the future.
Orentas RJ; Kohler ME; Johnson BD
Semin Cancer Biol; 2006 Apr; 16(2):137-49. PubMed ID: 16376101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
